| Literature DB >> 16530013 |
Øyvind Molberg1, Ludvig M Sollid.
Abstract
Major advances have been made in the molecular understanding of coeliac disease, initiated by the identification of intestinal gluten-reactive T cells. It is now clear that this common intestinal disorder, which is precipitated by the ingestion of wheat gluten, is mediated by DQ2-restricted T cells specific for gluten peptides modified by transglutaminase 2, the same enzyme that is targeted by disease-specific autoantibodies. Interestingly, many of the important features identified in coeliac disease, including HLA association, target organ T-cell infiltration, disease-specific autoantibodies and the distinct targeting of in vivo modified antigens, are also present in rheumatoid arthritis. The experiences from coeliac disease should therefore help identify disease-relevant T-cell epitopes in rheumatoid arthritis.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16530013 DOI: 10.1016/j.it.2006.02.006
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 16.687